| 2020 |
| 10/22 | 990 | 990 | 970 | 973 | -1.32% | 42,300 | 552億8011万 | -9.57% |
| 10/21 | 975 | 1,001 | 975 | 986 | +1.13% | 41,000 | 560億1869万 | -9.04% |
| 10/20 | 990 | 1,007 | 975 | 975 | -2.6% | 50,500 | 553億9374万 | -10.63% |
| 10/19 | 994 | 1,014 | 991 | 1,001 | +1.52% | 43,700 | 568億7090万 | -8.75% |
| 10/16 | 990 | 1,007 | 986 | 986 | -1.4% | 57,900 | 560億1869万 | -10.45% |
| 10/15 | 1,014 | 1,015 | 1,000 | 1,000 | -2.06% | 48,900 | 568億1409万 | -9.5% |
| 10/14 | 1,035 | 1,043 | 1,017 | 1,021 | -1.45% | 37,800 | 580億718万 | -7.85% |
| 10/13 | 1,040 | 1,050 | 1,035 | 1,036 | -1.33% | 41,700 | 588億5940万 | -6.67% |
| 10/12 | 1,057 | 1,063 | 1,045 | 1,050 | -1.04% | 19,400 | 596億5479万 | -5.49% |
| 10/09 | 1,056 | 1,064 | 1,045 | 1,061 | +0.19% | 61,500 | 602億7975万 | -4.59% |
| 10/08 | 1,055 | 1,073 | 1,055 | 1,059 | -0.19% | 52,300 | 601億6612万 | -4.85% |
| 10/07 | 1,072 | 1,076 | 1,058 | 1,061 | -1.67% | 52,100 | 602億7975万 | -4.76% |
| 10/06 | 1,088 | 1,090 | 1,073 | 1,079 | -0.83% | 44,100 | 613億240万 | -3.14% |
| 10/05 | 1,081 | 1,109 | 1,081 | 1,088 | +1.49% | 49,000 | 618億1373万 | -2.25% |
| 10/02 | 1,100 | 1,113 | 1,065 | 1,072 | -2.99% | 99,500 | 609億470万 | -3.6% |
| 09/30 | 12:30 変形性関節症治療剤SI-613の韓国における販売提携に関する契約締結のお知らせ |
| 09/30 | 1,123 | 1,170 | 1,103 | 1,105 | -2.39% | 92,100 | 627億7957万 | -0.54% |
| 09/29 | 1,131 | 1,144 | 1,112 | 1,132 | -0.35% | 69,900 | 643億1355万 | +2.07% |
| 09/28 | 1,098 | 1,141 | 1,092 | 1,136 | +4.41% | 164,000 | 645億4080万 | +2.81% |
| 09/25 | 1,166 | 1,169 | 1,088 | 1,088 | -6.85% | 254,000 | 618億1373万 | -1.18% |
| 09/24 | 18:00 連結業績予想及び配当予想に関するお知らせ |
| 09/24 | 1,159 | 1,181 | 1,159 | 1,168 | +0.17% | 69,100 | 663億5886万 | +6.28% |
| 09/23 | 1,151 | 1,176 | 1,141 | 1,166 | -0.6% | 68,400 | 662億4523万 | +6.68% |
| 09/18 | 1,160 | 1,190 | 1,160 | 1,173 | +1.3% | 79,200 | 666億4293万 | +7.71% |
| 09/17 | 1,169 | 1,185 | 1,150 | 1,158 | -1.19% | 52,000 | 657億9071万 | +6.83% |
| 09/16 | 1,154 | 1,175 | 1,135 | 1,172 | +1.56% | 59,100 | 665億8611万 | +8.52% |
| 09/15 | 1,163 | 1,166 | 1,146 | 1,154 | -1.28% | 44,300 | 655億6346万 | +7.25% |
| 09/14 | 1,172 | 1,194 | 1,160 | 1,169 | +0.78% | 75,600 | 664億1567万 | +9.05% |
| 09/11 | 1,160 | 1,167 | 1,143 | 1,160 | +2.56% | 93,000 | 659億434万 | +8.82% |
| 09/10 | 1,099 | 1,143 | 1,098 | 1,131 | +3.19% | 93,900 | 642億5673万 | +6.6% |
| 09/09 | 1,077 | 1,098 | 1,068 | 1,096 | -0.45% | 67,000 | 622億6824万 | +3.79% |
| 09/08 | 1,063 | 1,101 | 1,063 | 1,101 | +3.57% | 50,000 | 625億5231万 | +4.46% |
| 09/07 | 1,060 | 1,077 | 1,058 | 1,063 | +0.28% | 46,600 | 603億9338万 | +0.95% |
| 09/04 | 1,053 | 1,068 | 1,046 | 1,060 | -1.03% | 48,500 | 602億2293万 | +0.95% |
| 09/03 | 1,098 | 1,098 | 1,070 | 1,071 | -0.46% | 29,100 | 608億4789万 | +1.9% |
| 09/02 | 1,091 | 1,091 | 1,061 | 1,076 | -0.74% | 32,300 | 611億3196万 | +2.48% |
| 09/01 | 1,086 | 1,095 | 1,071 | 1,084 | -0.09% | 57,400 | 615億8647万 | +3.24% |
| 08/31 | 1,095 | 1,117 | 1,078 | 1,085 | +1.5% | 78,500 | 616億4329万 | +3.24% |
| 08/28 | 1,065 | 1,117 | 1,051 | 1,069 | +1.52% | 176,300 | 607億3426万 | +1.81% |
| 08/27 | 11:00 Dalton Chemical Laboratories, Inc.におけるVIDO-InterVacとの新型コロナウイルス感染症（COVID-19）ワクチン開発の提携に関するお知らせ |
| 08/27 | 1,054 | 1,245 | 1,029 | 1,053 | -0.47% | 631,600 | 598億2523万 | +0.29% |
| 08/26 | 1,040 | 1,061 | 1,030 | 1,058 | +1.24% | 37,300 | 601億931万 | +0.67% |
| 08/25 | 1,046 | 1,063 | 1,035 | 1,045 | -0.29% | 49,800 | 593億7072万 | -0.57% |
| 08/24 | 1,031 | 1,048 | 1,029 | 1,048 | +1.65% | 42,600 | 595億4116万 | -0.38% |
| 08/21 | 1,050 | 1,053 | 1,022 | 1,031 | -1.34% | 30,000 | 585億7532万 | -2.09% |
| 08/20 | 1,029 | 1,046 | 1,025 | 1,045 | +1.36% | 31,400 | 593億7072万 | -0.95% |
| 08/19 | 1,034 | 1,040 | 1,025 | 1,031 | -0.29% | 21,200 | 585億7532万 | -2.46% |
| 08/18 | 1,042 | 1,056 | 1,028 | 1,034 | -1.24% | 52,600 | 587億4577万 | -2.08% |
| 08/17 | 1,054 | 1,054 | 1,034 | 1,047 | -0.66% | 23,200 | 594億8435万 | -1.04% |
| 08/14 | 1,068 | 1,070 | 1,053 | 1,054 | -1.5% | 30,700 | 598億8205万 | -0.47% |
| 08/13 | 1,077 | 1,077 | 1,056 | 1,070 | -0.47% | 48,700 | 607億9107万 | +0.75% |
| 08/12 | 1,049 | 1,075 | 1,048 | 1,075 | +2.38% | 53,000 | 610億7514万 | +1.03% |
| 08/11 | 1,013 | 1,054 | 1,011 | 1,050 | +4.06% | 55,900 | 596億5479万 | -1.5% |
| 08/07 | 1,030 | 1,036 | 1,003 | 1,009 | -1.94% | 44,400 | 573億2541万 | -5.52% |
| 08/06 | 1,019 | 1,040 | 1,011 | 1,029 | +0.49% | 52,100 | 584億6170万 | -3.92% |
| 08/05 | 1,032 | 1,046 | 1,015 | 1,024 | -1.16% | 45,600 | 581億7763万 | -4.74% |
| 08/04 | 1,071 | 1,080 | 1,027 | 1,036 | -3.27% | 27,900 | 588億5940万 | -4.16% |
| 08/03 | 991 | 1,088 | 983 | 1,071 | +7.42% | 73,600 | 608億4789万 | -1.38% |
| 07/31 | 15:00 2021年3月期第1四半期決算短信〔日本基準〕(連結) |
| 07/31 | 1,046 | 1,054 | 960 | 997 | -7.08% | 69,600 | 566億4365万 | -8.45% |
| 07/30 | 1,070 | 1,090 | 1,039 | 1,073 | +1.13% | 39,900 | 609億6152万 | -2.01% |
| 07/29 | 1,083 | 1,089 | 1,060 | 1,061 | -1.94% | 26,500 | 602億7975万 | -3.46% |
| 07/28 | 1,092 | 1,100 | 1,076 | 1,082 | -0.92% | 22,900 | 614億7284万 | -1.99% |
| 07/27 | 1,059 | 1,092 | 1,052 | 1,092 | +3.31% | 40,700 | 620億4098万 | -1.53% |
| 07/22 | 1,084 | 1,084 | 1,057 | 1,057 | -2.49% | 27,600 | 600億5249万 | -4.95% |
| 07/21 | 1,054 | 1,091 | 1,053 | 1,084 | +2.26% | 54,500 | 615億8647万 | -2.95% |
| 07/20 | 1,063 | 1,065 | 1,051 | 1,060 | -0.28% | 24,800 | 602億2293万 | -5.36% |
| 07/17 | 1,084 | 1,093 | 1,062 | 1,063 | -1.85% | 30,800 | 603億9338万 | -5.26% |
| 07/16 | 1,071 | 1,089 | 1,071 | 1,083 | +1.5% | 44,900 | 615億2966万 | -3.73% |
| 07/15 | 1,082 | 1,082 | 1,056 | 1,067 | -1.39% | 73,900 | 606億2063万 | -5.32% |
| 07/14 | 1,082 | 1,096 | 1,077 | 1,082 | 0% | 26,500 | 614億7284万 | -4.33% |
| 07/13 | 1,049 | 1,085 | 1,044 | 1,082 | +5.05% | 40,800 | 614億7284万 | -4.5% |
| 07/10 | 10:00 譲渡制限付株式報酬としての自己株式の処分の払込完了に関するお知らせ |
| 07/10 | 1,064 | 1,067 | 1,030 | 1,030 | -3.65% | 70,900 | 585億1851万 | -9.33% |
| 07/09 | 1,081 | 1,086 | 1,069 | 1,069 | -0.93% | 56,400 | 607億3426万 | -6.23% |
| 07/08 | 1,124 | 1,148 | 1,079 | 1,079 | -4.17% | 74,800 | 613億240万 | -5.6% |
| 07/07 | 1,130 | 1,148 | 1,119 | 1,126 | -0.35% | 63,400 | 639億7266万 | -1.75% |
| 07/06 | 1,114 | 1,136 | 1,112 | 1,130 | +1.62% | 46,400 | 641億9992万 | -1.31% |
| 07/03 | 1,096 | 1,115 | 1,096 | 1,112 | +0.54% | 42,000 | 631億7727万 | -2.88% |
| 07/02 | 1,097 | 1,127 | 1,096 | 1,106 | +1.56% | 71,400 | 628億3638万 | -3.49% |
| 07/01 | 1,127 | 1,130 | 1,084 | 1,089 | -3.8% | 81,700 | 618億7054万 | -5.22% |
| 06/30 | 1,170 | 1,173 | 1,132 | 1,132 | -1.91% | 56,800 | 643億1355万 | -1.65% |
| 06/29 | 1,165 | 1,168 | 1,145 | 1,154 | -1.03% | 40,000 | 655億6346万 | +0.35% |
| 06/26 | 17:00 (開示事項の経過)Dalton Chemical Laboratories, Inc.の株式取得(子会社化)の完了及び特定子会社の異動に関するお知らせ |
| 06/26 | 1,148 | 1,171 | 1,148 | 1,166 | +1.92% | 42,500 | 662億4523万 | +1.66% |
| 06/25 | 1,143 | 1,154 | 1,136 | 1,144 | -1.12% | 28,000 | 649億9532万 | 0% |
| 06/24 | 1,171 | 1,171 | 1,155 | 1,157 | -1.45% | 21,900 | 657億3390万 | +1.31% |
| 06/23 | 1,193 | 1,194 | 1,156 | 1,174 | -0.68% | 42,300 | 666億9974万 | +2.98% |
| 06/22 | 1,191 | 1,195 | 1,176 | 1,182 | -1.58% | 32,600 | 671億5425万 | +3.78% |
| 06/19 | 16:00 譲渡制限付株式報酬としての自己株式の処分に関するお知らせ |
| 06/19 | 1,180 | 1,206 | 1,170 | 1,201 | +2.21% | 70,700 | 682億3372万 | +5.63% |
| 06/18 | 1,172 | 1,180 | 1,163 | 1,175 | +0.69% | 35,500 | 667億5655万 | +3.71% |
| 06/17 | 1,158 | 1,180 | 1,154 | 1,167 | +0.43% | 36,900 | 663億204万 | +3.37% |
| 06/16 | 1,138 | 1,163 | 1,121 | 1,162 | +5.06% | 59,600 | 660億1797万 | +3.11% |
| 06/15 | 1,139 | 1,162 | 1,106 | 1,106 | -3.07% | 52,100 | 628億3638万 | -1.78% |
| 06/12 | 1,125 | 1,154 | 1,116 | 1,141 | 0% | 75,100 | 648億2488万 | +1.33% |
| 06/11 | 14:00 変形性関節症治療剤ONO-5704/SI-613の変形性膝関節症患者を対象とした国内第III相臨床試験結果の学会発表に関するお知らせ |
| 06/11 | 1,176 | 1,197 | 1,138 | 1,141 | -2.56% | 109,300 | 648億2488万 | +1.51% |
| 06/10 | 1,149 | 1,177 | 1,135 | 1,171 | +2.81% | 59,400 | 665億2930万 | +4.46% |
| 06/09 | 1,160 | 1,160 | 1,132 | 1,139 | -0.7% | 38,100 | 647億1125万 | +1.97% |
| 06/08 | 1,132 | 1,147 | 1,123 | 1,147 | +1.59% | 28,900 | 651億6576万 | +2.96% |
| 06/05 | 1,140 | 1,142 | 1,120 | 1,129 | -1.05% | 39,600 | 641億4311万 | +1.62% |
| 06/04 | 1,158 | 1,163 | 1,128 | 1,141 | -0.52% | 31,500 | 648億2488万 | +2.79% |
| 06/03 | 1,125 | 1,150 | 1,118 | 1,147 | +3.15% | 65,000 | 651億6576万 | +3.52% |
| 06/02 | 1,129 | 1,129 | 1,110 | 1,112 | -1.42% | 59,700 | 631億7727万 | +0.63% |
| 06/01 | 1,145 | 1,148 | 1,122 | 1,128 | -1.66% | 43,100 | 640億8629万 | +2.17% |
| 05/29 | 1,163 | 1,172 | 1,133 | 1,147 | -1.97% | 96,600 | 651億6576万 | +4.18% |
| 05/28 | 1,149 | 1,172 | 1,135 | 1,170 | +3.27% | 64,800 | 664億7248万 | +6.65% |
| 05/21 | 11:00 癒着防止材SI-449のピボタル試験開始に関するお知らせ |
